195 related articles for article (PubMed ID: 23738724)
1. Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent.
Berthelsen R; Nielsen CU; Brodin B
J Pharm Pharmacol; 2013 Jul; 65(7):970-9. PubMed ID: 23738724
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
Nielsen CU; Amstrup J; Nielsen R; Steffansen B; Frokjaer S; Brodin B
Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
[TBL] [Abstract][Full Text] [Related]
3. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
4. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
6. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
7. Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2.
Irie M; Terada T; Okuda M; Inui K
Pflugers Arch; 2004 Nov; 449(2):186-94. PubMed ID: 15340850
[TBL] [Abstract][Full Text] [Related]
8. Distinct transport characteristics of basolateral peptide transporters between MDCK and Caco-2 cells.
Sawada K; Terada T; Saito H; Inui K
Pflugers Arch; 2001 Oct; 443(1):31-7. PubMed ID: 11692263
[TBL] [Abstract][Full Text] [Related]
9. Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers.
Nielsen CU; Carstensen M; Brodin B
Eur J Pharm Biopharm; 2012 Jun; 81(2):458-62. PubMed ID: 22452873
[TBL] [Abstract][Full Text] [Related]
10. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells.
Neumann J; Bruch M; Gebauer S; Brandsch M
Eur J Biochem; 2004 May; 271(10):2012-7. PubMed ID: 15128310
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
13. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
14. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
15. Transport of free and peptide-bound glycated amino acids: synthesis, transepithelial flux at Caco-2 cell monolayers, and interaction with apical membrane transport proteins.
Hellwig M; Geissler S; Matthes R; Peto A; Silow C; Brandsch M; Henle T
Chembiochem; 2011 May; 12(8):1270-9. PubMed ID: 21538757
[TBL] [Abstract][Full Text] [Related]
16. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.
Nakanishi T; Tamai I; Sai Y; Sasaki T; Tsuji A
Cancer Res; 1997 Sep; 57(18):4118-22. PubMed ID: 9307302
[TBL] [Abstract][Full Text] [Related]
18. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH.
Chen M; Singh A; Xiao F; Dringenberg U; Wang J; Engelhardt R; Yeruva S; Rubio-Aliaga I; Nässl AM; Kottra G; Daniel H; Seidler U
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G265-74. PubMed ID: 20430876
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of novel peptide transporter in renal basolateral membranes.
Terada T; Sawada K; Ito T; Saito H; Hashimoto Y; Inui K
Am J Physiol Renal Physiol; 2000 Nov; 279(5):F851-7. PubMed ID: 11053045
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rPEPT2-mediated Gly-Sar transport parameters in the rat kidney proximal tubule cell line SKPT-0193 cl.2 cultured in basic growth media.
Bravo SA; Nielsen CU; Frokjaer S; Brodin B
Mol Pharm; 2005; 2(2):98-108. PubMed ID: 15804184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
